NCT03908788View on ClinicalTrials.gov

Detection of the Emergence of RAS (Rat Sarcoma Viral Oncogene Homolog) Mutations in Circulating DNA (Deoxyribonucleic Acid) in Patients With mCRC (Metastatic Colorectal Cancer) During Treatment With Anti-EGFR (Epidermal Growth Factor Receptor) Therapy

NAActive, not recruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

July 26, 2018

Primary Completion Date

December 3, 2023

Study Completion Date

October 31, 2025

Conditions
Metastatic Colorectal Cancer
Interventions
DEVICE

Intplex test

Blood sample at each tumor assessment

Trial Locations (2)

34298

ICM Val d'Aurelle, Montpellier

Institut du Cancer de Montpellier - Val d'Aurelle, Montpellier

All Listed Sponsors
lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER

NCT03908788 - Detection of the Emergence of RAS (Rat Sarcoma Viral Oncogene Homolog) Mutations in Circulating DNA (Deoxyribonucleic Acid) in Patients With mCRC (Metastatic Colorectal Cancer) During Treatment With Anti-EGFR (Epidermal Growth Factor Receptor) Therapy | Biotech Hunter | Biotech Hunter